{"version":"1.0","type":"link","title":"CerS2 is a druggable target in triple-negative breast cancer.","author_name":"Alatawi H 외","author_url":"https://prs-insight.online/author/Alatawi%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75986","thumbnail_width":1200,"thumbnail_height":630}